LUKASZ SZARPAK to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications LUKASZ SZARPAK has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Connection Strength
0.474
-
Statins and the risk of pancreatic cancer: A systematic review and meta-analysis of 2,797,186 patients. Cardiol J. 2024; 31(2):243-250.
Score: 0.474
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.